RU94046297A - Новое бензодиазепиновое производное, способ его получения фармкомпозиция - Google Patents

Новое бензодиазепиновое производное, способ его получения фармкомпозиция

Info

Publication number
RU94046297A
RU94046297A RU94046297/04A RU94046297A RU94046297A RU 94046297 A RU94046297 A RU 94046297A RU 94046297/04 A RU94046297/04 A RU 94046297/04A RU 94046297 A RU94046297 A RU 94046297A RU 94046297 A RU94046297 A RU 94046297A
Authority
RU
Russia
Prior art keywords
cck
benzodiazepine derivative
receptor
pharmcomposition
synthesis
Prior art date
Application number
RU94046297/04A
Other languages
English (en)
Inventor
Сатох Масато
Jp]
Окамото Есинори
Косио Хироюки
Нисида Акито
Мията Кейдзи
Охта Митсуаки
Райдер Хеймиш
А.Кендрик Дэвид
Семпл Грим
Зелке Майкл
Gb]
Original Assignee
Яманоути Фармасьютикал Ко.
Яманоути Фармасьютикал Ко., Лтд.
Лтд. (Jp)
Ферринг Би.Ви.
Ферринг Би.Ви. (NL)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Яманоути Фармасьютикал Ко., Яманоути Фармасьютикал Ко., Лтд., Лтд. (Jp), Ферринг Би.Ви., Ферринг Би.Ви. (NL) filed Critical Яманоути Фармасьютикал Ко.
Publication of RU94046297A publication Critical patent/RU94046297A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Предлагается новое бензодиазепиновое производное, представляемое формулой, приведенной в формуле изобретения, или его фармацевтически приемлемые соли. Эти соединения являются полезными в качестве медицинских препаратов, в частности при лечении и предупреждении заболеваний, связанных с функционированием CCK-B-рецептора и гастринового рецептора, поскольку они обладают CCK-B-рецепторным антагонизмом, гастриновым рецепторным антагонизмом и оказывают ингибирующее действие на секрецию желудочного сока.

Claims (1)

  1. Предлагается новое бензодиазепиновое производное, представляемое формулой, приведенной в формуле изобретения, или его фармацевтически приемлемые соли. Эти соединения являются полезными в качестве медицинских препаратов, в частности при лечении и предупреждении заболеваний, связанных с функционированием CCK-B-рецептора и гастринового рецептора, поскольку они обладают CCK-B-рецепторным антагонизмом, гастриновым рецепторным антагонизмом и оказывают ингибирующее действие на секрецию желудочного сока.
RU94046297/04A 1992-06-24 1993-06-22 Новое бензодиазепиновое производное, способ его получения фармкомпозиция RU94046297A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPHEI-4-189826 1992-06-24
JP18982692 1992-06-24

Publications (1)

Publication Number Publication Date
RU94046297A true RU94046297A (ru) 1996-11-27

Family

ID=16247861

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94046297/04A RU94046297A (ru) 1992-06-24 1993-06-22 Новое бензодиазепиновое производное, способ его получения фармкомпозиция

Country Status (8)

Country Link
EP (1) EP0647632A1 (ru)
KR (1) KR950702191A (ru)
AU (1) AU670597B2 (ru)
CA (1) CA2138129A1 (ru)
FI (1) FI945989A0 (ru)
HU (1) HUT68208A (ru)
RU (1) RU94046297A (ru)
WO (1) WO1994000438A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2282594A (en) * 1993-08-25 1995-04-12 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives
GB2282595A (en) * 1993-08-25 1995-04-12 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6506782B1 (en) 1998-02-27 2003-01-14 Athena Neurosciences, Inc. Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6958330B1 (en) 1998-06-22 2005-10-25 Elan Pharmaceuticals, Inc. Polycyclic α-amino-ε-caprolactams and related compounds
US6509331B1 (en) 1998-06-22 2003-01-21 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6569851B1 (en) 1998-06-22 2003-05-27 Elan Pharmaceutials, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6528505B1 (en) 1998-06-22 2003-03-04 Elan Pharmaceuticals, Inc. Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6552013B1 (en) 1998-06-22 2003-04-22 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6774125B2 (en) 1998-06-22 2004-08-10 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
FR2782997A1 (fr) * 1998-09-08 2000-03-10 Hoechst Marion Roussel Inc Nouveaux derives de la benzodiazepinone, procede de preparation et intermediaires de ce procede, application a titre de medicaments et compositions pharmaceutiques les renfermant
EP1142868A4 (en) * 1998-12-22 2004-09-29 Mitsubishi Chem Corp amide derivatives
ATE275403T1 (de) 1999-12-02 2004-09-15 Zeria Pharm Co Ltd Kalziumsalze von 1,5-benzodiazepin-derivaten, verfahren zu deren herstellung und diese enthaltende medikamente

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430455D0 (en) * 1984-12-03 1985-01-09 Fujisawa Pharmaceutical Co Fr-900506 substance
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs
EP0358508A3 (en) * 1988-09-08 1991-03-20 Merck & Co. Inc. Novel immunosuppressant compound
GB2225576B (en) * 1988-11-29 1992-07-01 Sandoz Ltd Substituted azatricyclo derivatives and metabolites,their preparation and pharmaceutical compositions containing them
CA2099672A1 (en) * 1990-12-25 1992-06-26 Masato Satoh Benzodiazepine derivatives
WO1993008175A1 (en) * 1991-10-24 1993-04-29 Glaxo Group Limited Benzodiazepine derivatives as antagonists of gastrin and/or cholecystokinin

Also Published As

Publication number Publication date
HUT68208A (en) 1995-06-28
AU670597B2 (en) 1996-07-25
AU4357093A (en) 1994-01-24
HU9403785D0 (en) 1995-02-28
EP0647632A4 (ru) 1995-04-19
FI945989A (fi) 1994-12-21
WO1994000438A1 (en) 1994-01-06
CA2138129A1 (en) 1994-01-06
EP0647632A1 (en) 1995-04-12
FI945989A0 (fi) 1994-12-21
KR950702191A (ko) 1995-06-19

Similar Documents

Publication Publication Date Title
RU94046297A (ru) Новое бензодиазепиновое производное, способ его получения фармкомпозиция
RU94040864A (ru) Конденсированные индольные производные, их получение, фармацевтическая композиция
NO985711D0 (no) Farmas°ytikum for behandling av neurologiske og neuropsykiatriske mangler
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
DE69530081T2 (de) Gastrin- und cck-antagonisten
RU94044671A (ru) Применение непептидных антагонистов рецептора тахикинина
RU95116357A (ru) Производные пирролидина и тиазолидина, способы их получения, способ разделения энантиомеров и фармацевтическая композиция на основе производных пирролидина и тиазолидина
RU94045278A (ru) Применение 2-фенил-3-ароилбензтиофенов для ингибирования вазомоторных симптомов и сопутствующих психологических нарушений, ассоциированных с постклимактерическим синдромом
AU5835194A (en) Thiazolidine derivatives, preparation thereof and drugs containing same
RU94042907A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ ее получения
MX9706605A (es) Derivados de indol como antagonistas de los aminoacidos exitadores.
RU94044454A (ru) Ингибитор аутоимунных заболеваний
RU94019981A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ их получения
RU94038255A (ru) Производные бензодиазепина, способ их получения, фармацевтическая композиция
ZA952614B (en) The use of carboxylic acid derivatives as drugs
DE69315699D1 (de) Inhibitoren gegen die aggregation von blutplättchen
EP0591529A4 (en) NEW BENZODIAZEPINE DERIVATIVE.
SE9302333D0 (sv) New compounds
AU5819294A (en) N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
HU9503099D0 (en) New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные
NO932325L (no) Nye benzodiazepinderivater
NO945033L (no) Nye benzodiazepinderivater